9 doctors weighed in:
Is it better to be her 2 positive or her2 negative?
9 doctors weighed in

Dr. Kathleen Ruddy
Breast Surgery
5 doctors agree
In brief: Her2 positive
Breast cancer is broken into 4 types - each involves the presence or absence of estrogen, progesterone, and her 2 receptors: luminal a (er/pr positive, her 2 negative), luminal b (er/pr positive, her 2 positive), her 2 (er/pr negative, her 2 positive), triple-negative (er/pr negative, her 2 negative).
Patients who are her 2 positive herceptin, (trastuzumab) a powerful drug that greatly improves survival.

In brief: Her2 positive
Breast cancer is broken into 4 types - each involves the presence or absence of estrogen, progesterone, and her 2 receptors: luminal a (er/pr positive, her 2 negative), luminal b (er/pr positive, her 2 positive), her 2 (er/pr negative, her 2 positive), triple-negative (er/pr negative, her 2 negative).
Patients who are her 2 positive herceptin, (trastuzumab) a powerful drug that greatly improves survival.
Dr. Kathleen Ruddy
Dr. Kathleen Ruddy
Thank
Dr. Devon Webster
Internal Medicine - Oncology
1 doctor agrees
In brief: I'd rather be pos!
Her2 positive breast cancer used to be the worst type, and now it is probably the best type.
That's because there are several excellent targeted therapies to effectively treat Her2 positive cancer if it comes back. My patients with metastatic breast cancer who are Her2 positive have the longest lifespans. And I'm happy when their cancer is Her2 positive.

In brief: I'd rather be pos!
Her2 positive breast cancer used to be the worst type, and now it is probably the best type.
That's because there are several excellent targeted therapies to effectively treat Her2 positive cancer if it comes back. My patients with metastatic breast cancer who are Her2 positive have the longest lifespans. And I'm happy when their cancer is Her2 positive.
Dr. Devon Webster
Dr. Devon Webster
Thank
Dr. Eric Brown
Breast Surgery
In brief: Her2 neg
Her2 (+) cancers tend to be more aggressive.
Although targeted therapy w herceptin, (trastuzumab) given along w chemotherapy, then on its own for one year, has improved survival, it is still a more aggressive sub-type of breast cancer.

In brief: Her2 neg
Her2 (+) cancers tend to be more aggressive.
Although targeted therapy w herceptin, (trastuzumab) given along w chemotherapy, then on its own for one year, has improved survival, it is still a more aggressive sub-type of breast cancer.
Dr. Eric Brown
Dr. Eric Brown
Thank
Get help from a real doctor now
Dr. Buck Parker
Board Certified, Surgery
13 years in practice
467K people helped
Continue
108,000 doctors available
Read more answers from doctors